Skip to main content
. Author manuscript; available in PMC: 2021 Mar 29.
Published in final edited form as: Neuroradiology. 2016 Dec 2;59(1):5–12. doi: 10.1007/s00234-016-1766-y

Fig. 4.

Fig. 4

Scatterplots between the difference in ADC (ΔADC), and respectively CVR, baseline ATT, and change in ATT (ΔATT). The absence of significant correlation (r) in all three graphs speaks for the safety of the acetazolamide challenge to test CVR in moyamoya patients